Results about: colorectal cancer
Colorectal cancer (CRC) is the most frequent and the second-most deadly type of cancer with around 700,000 deaths worldwide.
The IRB Barcelona scientist and head of the Colorectal Cancer Lab has been awarded the Olof Palme Medal in recognition of his recent discovery regarding the treatment of advanced-stage colon tumors with immunotherapy.
IRB Barcelona paves the way to the use of immunotherapy to treat aggressive colon tumours and their metastasis
A team headed by ICREA researcher Eduard Batlle discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer.
The researchers developed a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time.
Olga Torres Foundation awards IRB Barcelona a grant to study immunotherapies for metastatic colorectal cancer
The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.
The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Research will take place during the academic years 2017 and 2018.